Le Lézard
Classified in: Health, Science and technology, Business
Subjects: BOARD OF DIRECTORS, SHAREHOLDER RIGHTS PLANS

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares


LONDON and PHOENIX, Nov. 22, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 24,500 ACUT shares in the open market. This brings his total holding to 3,855,723 shares.

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor "stemness," we believe our tools will help care teams better understand the biology of each patient's cancer, leading to more informed decision making. For more information, please visit www.accustem.com.

Media Contact:
Jeff Fensterer
Phone: 415-640-6010
Email: [email protected]

Investor Contact:
Wendy Blosser
Email: [email protected]



These press releases may also interest you

at 10:00
inriver, the leading software company powering the entire product journey with revenue-driving product information management (PIM) across every customer touchpoint, today showcased exceptional customers and partners and announced industry award...

at 09:58
HiBy, a leader in the portable audio industry, today announces its R4 HiFi Digital Audio Player and opens presale of the product on its ecommerce website....

at 09:52
Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion", 01157.HK) proudly showcased its latest advancements at INTERMAT, held at the Nord Villepinte Exhibition Center in Paris from April 24-27, 2024. Themed "Greener Development, Brighter...

at 09:50
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:49
Electric Scooter, 4Pro (2nd Gen), which is produced by Brightway Innovation Intelligent Technology (Suzhou) Co.,Ltd., is unveiled recently. Xiaomi Unveils 4Pro (2nd Gen) Xiaomi made waves with the unveiling of its latest Electric Scooter, 4Pro (2nd...

at 09:48
Oracle CloudWorld - Oracle today announced new artificial intelligence (AI) capabilities within Oracle Fusion Cloud Customer Experience (CX) to help marketers, sellers, and service agents accelerate deal cycles. The new AI capabilities will help...



News published on and distributed by: